Occurrence, fate, and persistence of gemfibrozil in water and soil

Environmental Toxicology and Chemistry

Volumn 31, Issue 3, 2012, Pages 550-555

  Fang, Yu ^a,b   Karnjanapiboonwong, Adcharee ^a   Chase, Darcy A ^a   Wang, Jiafan ^a   Morse, Audra N ^c   Anderson, Todd A ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b XIAMEN UNIVERSITY   (China)

^c Department of Electrical and Computer Engineering   (United States)

Author keywords

Biodegradation; Groundwater; Pharmaceuticals; Sorption; Wastewater

Indexed keywords

AEROBIC CONDITION; BATCH EQUILIBRIUM METHOD; BIOLOGICAL DEGRADATION; ENVIRONMENTAL CONTAMINANT; GEMFIBROZILS; HALF LIVES; LAND APPLICATIONS; LOAM SOILS; ORGANIC CARBON CONTENTS; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; SANDY LOAMS; SILT LOAM; SILT LOAM SOILS; SOIL TYPES; SOIL-WATER DISTRIBUTION; SORPTION CAPACITIES; TREATED EFFLUENT; WASTEWATER TREATMENT PLANTS;

BIODEGRADATION; DEGRADATION; DRUG PRODUCTS; GROUNDWATER; MICROBIOLOGY; SILT; SOIL CONDITIONERS; SORPTION; WASTEWATER; WASTEWATER TREATMENT; WATER SUPPLY SYSTEMS;

EFFLUENTS;

GEMFIBROZIL; GROUND WATER; ORGANIC CARBON;

BIODEGRADATION; DRUG; EFFLUENT; ENVIRONMENTAL ASSESSMENT; ENVIRONMENTAL FATE; EQUILIBRIUM; GROUNDWATER; HALF LIFE; ORGANIC CARBON; PERSISTENCE; SANDY LOAM; SILTY LOAM; SOIL TYPE; SORPTION; WASTEWATER; WATER TREATMENT;

ABSORPTION; ARTICLE; BIODEGRADATION; CONCENTRATION (PARAMETERS); EFFLUENT; LOAM SOIL; PRIORITY JOURNAL; SAND; SANDY LOAM; SILT LOAM SOIL; WASTE WATER TREATMENT PLANT; WATER SUPPLY;

BIODEGRADATION, ENVIRONMENTAL; ENVIRONMENTAL MONITORING; GEMFIBROZIL; GROUNDWATER; HYPOLIPIDEMIC AGENTS; SOIL; SOIL POLLUTANTS; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

EID: 84862777977     PISSN: 07307268     EISSN: 15528618     Source Type: Journal    
DOI: 10.1002/etc.1725     Document Type: Article

References (46)

1. Heberer T. 2002. Occurrence, fate and removal of pharmaceutical residues in the aquatic environment: A review of recent research to date. Toxicol Lett 131: 5- 17.
2. Kümmerer K. 2001. Drugs in the environment: Emission of drugs, diagnostic aids disinfectants into wastewater by hospitals in relation to other sources-A review. Chemosphere 45: 957- 969.
3. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ Sci Technol 36: 1202- 1211.
4. Yu JT, Bouwer EJ, Coelhan M. 2006. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agricult Water Manag 86: 72- 80.
5. Daughton CG, Ternes TA. 1999. Pharmaceuticals and personal care products in the environment: Agents of the subtle changes? Environ Health Perspect 107: 907- 938.
6. Legler J, Brouwer A. 2003. Are brominated flame retardants endocrine disruptors? Environ Int 29: 879- 885.
7. Wilson BA, Smith VH, Denoyelles F, Larive CK. 2003. Effects of three pharmaceutical and personal care products on natural freshwater algal assemblages. Environ Sci Technol 37: 1713- 1719.
8. International Agency for Research on Cancer. 1996. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Overall evaluation of carcinogenicity: an updating of IARC monographs, Vol 60. Lyon, France, pp 427.
9. Gonzalez FJ. 1997. The role of peroxisome proliferators activated receptor alpha in peroxisome proliferation, physiological homeostasis, and chemical carcinogenesis. In Dietary Fat and Cancer: Genetic and Molecular Interations. Plenum, Washington, DC, USA, pp 109- 125.
10. Xia K, Bhandari A, Das K, Pillar G. 2005. Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids. J Environ Qual 34: 91- 104.
11. Keller H, Xia K, Bhandari A. 2003. Occurrence and degradation of estrogenic nonylphenol and its precursors in northeast Kansas wastewater treatment plants. J Hazard Toxic Radioact Waste 7: 203- 213.
12. Johnson AC, Belfroid A, Di Corcia A. 2000. Estimating steroid oestrogen inputs into activated sludge treatment works and observations on their removal from the effluent. Sci Total Environ 256: 163- 173.
13. Stumpf M, Ternes TA, Wilken RD, Rodrigues SV, Baumann W. 1999. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225: 135- 141.
14. Bendz D, Paxéus N, Ginn T, Loge F. 2005. Occurrence and fate of pharmaceutically active compounds in aquatic environment, a case study: Höje River in Sweden. J Hazard Mater 122: 195- 204.
15. Calamari D, Zuccato E, Castiglioni S, Bagnati R, Fanelli R. 2003. Strategic survey of therapeutic drugs in the Rivers Po and Lambro in northern Italy. Environ Sci Technol 37: 1241- 1248.
16. Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR. 2003. Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144: 383- 395.
17. Mimeault C, Woodhouse A, Miao X, Metcalfe C, Moon T, Trudeau V. 2005. The human lipid regulator gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassiuus auratus Aquat Toxicol 73: 44- 54.
18. Huertas E, Salgot M, Hollender J, Weber S, Dott W, Khan S, Schäfer A, Messalem R, Bis B, Aharon A, Chikurel H. 2008. Key objectives for water reuse concepts. Desalination 218: 120- 131.
19. Araujo L, Villa N, Camargo N, Bustos M, García T, Prieto A, de J. 2009. Persistence of gemfibrozil, naproxen and mefenamic acid in natural waters. Environ Chem Lett 9: 13- 18.
20. Kunkel U, Radke M. 2008. Biodegradation of acidic pharmaceuticals in bed sediments: Insight from a laboratory experiment. Environ Sci Technol 42: 7273- 7279.
21. Karnjanapiboonwong A, Suski JG, Shah AA, Cai QS, Morse AN, Anderson TA. 2011. Occurrence of PPCPs at a wastewater treatment plant and in soil and groundwater at a land application site. Water Air Soil Pollut 216: 257- 273.
22. Organisation for Economic Co-operation and Development. 2000. Guidelines for the testing of chemicals. Section 1: Physical-chemical properties. Test No. 106: Adsorption-desorption using a batch equilibrium method. Paris, France.
23. Carr DL, Morse AN, Zak JC, Anderson TA. 2011. Microbially mediated degradation of common pharmaceuticals and personal care products in soil under aerobic and reduced oxygen conditions. Water Air Soil Pollut 216: 633- 642.
24. Castiglioni S, Bagnati R, Fanelli R, Pomati F, Calamari D, Zuccato E. 2006. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 40: 357- 363.
25. Ellis JB. 2006. Pharmaceuticals and personal care products (PPCPs) in urban receiving waters. Environ Pollut 144: 184- 189.
26. Ternes TA. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32: 3245- 3260.
27. Snyder SA, Lei HX, Wert EC. 2008. Removal of endocrine disruptors and pharmaceuticals during water treatment. In Aga DS, ed, Fate of Pharmaceuticals in the Environment and in Water Treatment Systems. CRC, Boca Raton, FL, USA, pp 229- 259.
28. Sangsupan HA, Radcliffe DE, Hartel PG, Jenkins MB, Vencill WK, Cabrera ML. 2006. Sorption and transport of 17β-estradiol and testosterone in undisturbed soil columns. J Environ Qual 35: 2261- 2272.
29. Mansell J, Drewes JE, Rauch T. 2004. Removal mechanisms of endocrine disrupting compounds (steroids) during soil aquifer treatment. Water Sci Technol 50: 229- 237.
30. Snyder SA, Leising J, Westerhoff P, Yoon Y, Mash H, Vanderford B. 2004. Biological and physical attenuation of endocrine disruptors and pharmaceuticals: Implications for water reuse. Ground Water Monitoring & Remediation 24: 108- 118.
31. Overcash M, Sims RC, Sims JL, Nieman JKC. 2005. Beneficial reuse and sustainability: The fate of organic compounds in land-applied waste. J Environ Qual 34: 29- 51.
32. Kinney CA, Furlong ET, Werner SL, Cahill JD. 2006. Presence and distribution of wastewater-derived pharmaceuticals in soil irrigated with reclaimed water. Environ Toxicol Chem 25: 317- 326.
33. Mimeault C, Trudeau VL, Moon TW. 2006. Waterborne gemfibrozil challenges the hepatic antioxidant defense system and down-regulates peroxisome proliferator-activated receptor beta (PPARbeta) mRNA levels in male goldfish (Carassius auratus). Toxicology 228: 140- 150.
34. Zurita JL, Repetto G, Jos A, Salquero M, López-Artiquez M, Cameán AM. 2007. Toxicological effects of the lipid regulator gemfibrozil in four aquatic systems. Aquat Toxicol 81: 106- 115.
35. Hari AC, Paruchuri RA, Sabatini DA, Kibbey TCG. 2005. Effects of pH and cationic and nonionic surfactants on the adsorption of pharmaceuticals to a natural aquifer material. Environ Sci Technol 39: 2592- 2598.
36. Williams CF, Williams CF, Adamsen F. 2006. Sorption-desorption of carbamazepine from irrigated soils. J Environ Qual 35: 1779- 1783.
37. Blackwell PA, Kay P, Boxall ABA. 2007. The dissipation and transport of veterinary antibiotics in a sandy loam soil. Chemosphere 67: 292- 299.
38. U.S. Environmental Protection Agency. 2005. Pollution prevention (P2) Framework. EPA-748-B-04-001. Washington, DC.
39. Tolls J. 2001. Sorption of veterinary pharmaceuticals in soils: A review. Environ Sci Technol 35: 3397- 3406.
40. Urase T, Kikuta T. 2005. Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Res 39: 1289- 1300.
41. Ying GG, Yu XY, Kookana RS. 2007. Biological degradation of triclocarban and triclosan in a soil under aerobic and anaerobic conditions and comparison with environmental fate modelling. Environ Pollut 150: 300- 305.
42. Ingerslev F, Toräng L, Loke ML, Halling-Sørensen B, Nyholm N. 2001. Primary biodegradation of veterinary antibiotics in aerobic and anaerobic surface water simulation systems. Chemosphere 44: 865- 872.
43. Walters E, McClellan K, Halden RU. 2010. Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms. Water Res 44: 6011- 6020.
44. Al-Rajab AJ, Sabourin L, Scott A, Lapen DR, Topp E. 2009. Impact of biosolids on the persistence and dissipation pathway of triclosan and triclocarban in an agricultural soil. Sci Total Environ 407: 5978- 5985.
45. Hassan HB, Kata M, Erös I, Aigner Z. 2004. Preparation and investigation of inclusion complexes containing gemfibrozil and DIMEB. J Incl Phenom Macro 50: 219- 225.
46. Westerhoff P, Yoon Y, Snyder S, Wert E. 2005. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol 39: 6649- 6663.